Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | 0.00% | 0.00% | -40.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-40.00% | 532K | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.44% | 21.6B | |
-12.38% | 22.31B | |
-6.91% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- OVXA Stock
- News Ovoca Bio plc
- Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment